VIKING GLOBAL INVESTORS LP Insider Trading Transactions
Get free email notifications about insider trading for VIKING GLOBAL INVESTORS LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIKING GLOBAL INVESTORS LP. VIKING GLOBAL INVESTORS LP is 10% Owner in FIRST DATA CORP ($FDC) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and 10% Owner in Adaptive Biotechnologies Corp ($ADPT) and 10% Owner in Wayfair Inc. ($W) and 10% Owner in Axovant Sciences Ltd. ($AXON) and 10% Owner in 4D Molecular Therapeutics Inc. ($FDMT) and 10% Owner in Editas Medicine, Inc. ($EDIT) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and 10% Owner in Zentalis Pharmaceuticals, Inc. ($ZNTL) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in BridgeBio Pharma, Inc. ($BBIO) and 10% Owner in Urovant Sciences Ltd. ($UROV).
Latest Insider Trading Transactions of VIKING GLOBAL INVESTORS LP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FDMT, ADPT, TKMR, BBIO, EDIT, FDC, INBX, MYOV, AXON, UROV, W, ZNTL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 833,333 | 0 | 0 | |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 2,004,581 | 0 | 0 | |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 23.00 | 1,100,000 | 25,300,000 | 3,937,914 | 2.8 M to 3.9 M (+38.76 %) |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 833,333 | 0 | 2,837,914 | 2 M to 2.8 M (+41.57 %) |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 2,004,581 | 0 | 2,004,581 | 0 to 2 M |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 55.65 | 1,000,000 | 55,650,000 | 29,993,708 | 31 M to 30 M (-3.23 %) |
Nov 13 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 49.52 | 2,500,000 | 123,787,500 | 30,993,708 | 33.5 M to 31 M (-7.46 %) |
Aug 28 2020 | INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 18.99 | 100,000 | 1,898,700 | 1,427,307 | 1.3 M to 1.4 M (+7.53 %) |
Aug 28 2020 | INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 18.84 | 80,219 | 1,511,166 | 1,327,307 | 1.2 M to 1.3 M (+6.43 %) |
Aug 25 2020 | INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 19.39 | 70,479 | 1,366,588 | 1,247,088 | 1.2 M to 1.2 M (+5.99 %) |
Aug 25 2020 | INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 19.23 | 14,825 | 285,100 | 1,176,609 | 1.2 M to 1.2 M (+1.28 %) |
Aug 25 2020 | INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 19.43 | 46,161 | 897,001 | 1,161,784 | 1.1 M to 1.2 M (+4.14 %) |
Apr 08 2020 | ZNTL | Zentalis Pharmaceu ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 18.00 | 725,000 | 13,050,000 | 4,443,284 | 3.7 M to 4.4 M (+19.50 %) |
Apr 08 2020 | ZNTL | Zentalis Pharmaceu ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 18.00 | 725,000 | 13,050,000 | 4,443,284 | 3.7 M to 4.4 M (+19.50 %) |
Jan 30 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 24.98 | 4,912,899 | 122,706,039 | 33,493,708 | 38.4 M to 33.5 M (-12.79 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 290,572 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 2,007,740 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 15,524,350 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 18,908,945 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 290,572 | 0 | 38,406,607 | 38.1 M to 38.4 M (+0.76 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 2,007,740 | 0 | 38,116,035 | 36.1 M to 38.1 M (+5.56 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 15,524,350 | 0 | 36,108,295 | 20.6 M to 36.1 M (+75.42 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 18,908,945 | 0 | 20,583,945 | 1.7 M to 20.6 M (+1,128.89 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 20.00 | 250,000 | 5,000,000 | 1,675,000 | 1.4 M to 1.7 M (+17.54 %) |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 50,446,451 | 0 | 0 | |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 51,781,276 | 0 | 0 | |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 17.00 | 4,705,900 | 80,000,300 | 26,620,991 | 21.9 M to 26.6 M (+21.47 %) |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 10,178,954 | 0 | 21,915,091 | 11.7 M to 21.9 M (+86.73 %) |
Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 11,736,137 | 0 | 11,736,137 | 0 to 11.7 M |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 13 2019 | MYOV | Myovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 0 | -4,802 to 0 (-100.00 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 9,995.00 | 9,995 | 99,900,025 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 0 | -1,715 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 0 | -8,285 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 0 | -6,200 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
Mar 19 2019 | AXON | Axovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 1.50 | 6,666,667 | 10,000,001 | 105,952,381 | 99.3 M to 106 M (+6.71 %) |
Dec 20 2018 | AXON | Axovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 1.00 | 10,000,000 | 10,000,000 | 99,285,714 | 89.3 M to 99.3 M (+11.20 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Jun 07 2018 | AXON | Axovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 1.75 | 14,285,714 | 25,000,000 | 89,285,714 | 75 M to 89.3 M (+19.05 %) |
Apr 05 2018 | MYOV | Myovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
Jan 16 2018 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
Oct 17 2017 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 5,335 | 0 | 266,782 | 261.4 K to 266.8 K (+2.04 %) |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 261,447 | 0 | 261,447 | 0 to 261.4 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 481,567 | 0 | 481,567 | 0 to 481.6 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 15,072 | 0 | 15,072 | 0 to 15.1 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 256,986 | 0 | 256,986 | 0 to 257 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 20,407 | 0 | 2,729,808 | 2.7 M to 2.7 M (+0.75 %) |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 1,000,000 | 0 | 2,709,401 | 1.7 M to 2.7 M (+58.50 %) |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 5,874,105 | 0 | 0 | |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 10,144,738 | 0 | 0 | |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 317,519 | 0 | 0 | |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 5,413,702 | 0 | 0 | |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 21,750,064 | 0 | 0 | |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 5,874,105 | 0 | 5,874,105 | 0 to 5.9 M |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 10,144,738 | 0 | 10,144,738 | 0 to 10.1 M |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 317,519 | 0 | 317,519 | 0 to 317.5 K |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 5,413,702 | 0 | 5,413,702 | 0 to 5.4 M |
Apr 15 2016 | FDC | FIRST DATA CORP | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 21,750,064 | 0 | 21,750,064 | 0 to 21.8 M |
Nov 24 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 22.73 | 17,600 | 400,034 | 538,711 | 521.1 K to 538.7 K (+3.38 %) |
Nov 24 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 22.73 | 17,600 | 400,034 | 1,791,536 | 1.8 M to 1.8 M (+0.99 %) |
Nov 12 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 22,500 | 0 | 521,111 | 498.6 K to 521.1 K (+4.51 %) |
Nov 12 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 22,500 | 0 | 1,773,936 | 1.8 M to 1.8 M (+1.28 %) |
Nov 05 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 25.17 | 1,200 | 30,205 | 498,611 | 497.4 K to 498.6 K (+0.24 %) |
Nov 05 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 25.17 | 1,200 | 30,205 | 1,751,436 | 1.8 M to 1.8 M (+0.07 %) |
Oct 06 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 5,840 | 0 | 25,054 | 19.2 K to 25.1 K (+30.39 %) |
Oct 06 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 99,621 | 0 | 427,215 | 327.6 K to 427.2 K (+30.41 %) |
Oct 06 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 79,250 | 0 | 1,750,236 | 1.7 M to 1.8 M (+4.74 %) |
Oct 06 2014 | W | Wayfair Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 400,000 | 0 | 1,750,236 | 1.4 M to 1.8 M (+29.62 %) |
Page: 1